eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | scleroderma |
| Comorbidity | C0024115|lung disease |
| Sentences | 8 |
| PubMedID- 22723597 | Up-regulated expression of hla-drb5 transcripts and high frequency of the hla-drb5*01:05 allele in scleroderma patients with interstitial lung disease. |
| PubMedID- 24627847 | A case of sine scleroderma with parenchymal lung disease. |
| PubMedID- 20352228 | To evaluate the role and the prognostic value of bronchoalveolar lavage (bal) in scleroderma patients with interstitial lung disease. |
| PubMedID- 21552414 | Long term effects of cyclophosphamide treatment on lung function and survival in scleroderma patients with interstitial lung disease. |
| PubMedID- 21314931 | The aim of the study was to investigate the presence of thymosins beta4, beta4 sulfoxide, and beta10 in bronchoalveolar lavage fluid of scleroderma patients with interstitial lung disease and the relation of these factors with pulmonary functional and radiological parameters. |
| PubMedID- 25110305 | Good outcome of interstitial lung disease in patients with scleroderma associated to anti-pm/scl antibody. |
| PubMedID- 22402140 | This study aimed to evaluate vegf concentration in the bronchoalveolar lavage fluid (balf) of scleroderma patients with interstitial lung disease, to correlate the cytokine levels in plasma and in the lung with pulmonary functional, radiological and cellular parameters, and with the progression of lung disease. |
| PubMedID- 22826062 | Interstitial lung disease often coexists with scleroderma and is accompanied by functional lung abnormalities. |
Page: 1